Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €16.37 EUR
Change Today -0.07 / -0.43%
Volume 28.7K
As of 11:35 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

glanbia plc (GLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/20/15 - €19.59
52 Week Low
10/17/14 - €10.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GLANBIA PLC (GLB)

Related News

No related news articles were found.

glanbia plc (GLB) Related Businessweek News

View More BusinessWeek News

glanbia plc (GLB) Details

Glanbia plc operates as a nutrition and ingredients company worldwide. It offers performance nutrition products, including protein, pre-workout, muscle gainers and builders, and general health products under Optimum Nutrition, BSN, Isopure, Nutramino, and ABB brands; and American-style cheddar cheese, and dairy and non-dairy nutritional ingredients, as well as blends vitamins, minerals, and other nutrients to specifications of food and beverage customers. The company also provides consumer products, such as standard and fortified milks, cheese, butter, and cream, as well as chilled soups; supplies inputs to the agri sector; purchases and processes grains; and manufactures animal feed products. In addition, it offers fertilizers; nutrient delivery systems; management services; and business services, as well as operates as a beverage manufacturer and co-packer. Further, the company is involved in general trading, property and land dealing, financing, and research and development activities. Glanbia plc sells its products through various channels, including specialty retail, Internet, and gyms. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.

5,815 Employees
Last Reported Date: 04/9/15
Founded in 1964

glanbia plc (GLB) Top Compensated Officers

Group Managing Director and Executive Directo...
Total Annual Compensation: €1.4M
Group Finance Director and Executive Director
Total Annual Compensation: €750.0K
Executive Director and Chief Executive Office...
Total Annual Compensation: €750.0K
Executive Director and Chief Executive Office...
Total Annual Compensation: €709.0K
Compensation as of Fiscal Year 2014.

glanbia plc (GLB) Key Developments

Glanbia plc Presents at Berenberg Specialty Chemicals & Food Ingredients, Sep-30-2015

Glanbia plc Presents at Berenberg Specialty Chemicals & Food Ingredients, Sep-30-2015 . Venue: Berenberg Offices, 60 Threadneedle Street, London EC2R 8HP, United Kingdom. Speakers: Liam Hennigan, IR.

Glanbia Eyes Acquisitions

Glanbia plc (ISE:GL9) is seeking acquisitions. With an estimated warchest of €250 million for further mergers and acquisitions, Siobhan Talbot, Managing Director of Glanbia, didn't outline Glanbia's specific plans but said that as disciplined acquirers it retained a strong pipeline of potential deals.

Glanbia Announces Earnings Results for the First Half of 2015; Provides Earnings Guidance for the Year of 2015; Provides Capital Expenditure for 2016

Glanbia announced earnings results for the first half of 2015. The company announced a very strong first-half out-turn, delivering 25% EPS growth on a reported basis. Revenues in wholly owned businesses was EUR 1.4 billion for the first half, a 10.6% increase than last year on a reported basis and a decrease of 3.9% constant currency. The company reported wholly-owned EBITA of EUR 138.5, growing by 29.1% on a reported basis, and by 7.5% constant currency. Adjusted earnings per share, which excludes exceptional items in this prior to intangible amortization net of tax, were $0.406, an increase of 25.1% on a reported basis, and 4.2% on constant currency. Net debt was EUR 577 million compared to EUR 472 million at the same time in 2014. Year-to-date capital expenditure has amounted to EUR 59 million. Guidance for full year of 2015, EPS growth has been maintained at 9% to 11% in constant currency terms. At the end of the year, the company expects the group's net debt level to be below EUR 500 million based on current projections and assuming no further significant strengthening of the dollar. The company expects capital expenditure of between EUR 120 million and EUR 130 million. For 2016, the company expects capital expenditure to be over EUR 100 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLB:LN €16.37 EUR -0.07

GLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Devro PLC 300.00 GBp +1.25
Greencore Group PLC 293.50 GBp +14.10
Herbalife Ltd $55.72 USD +1.58
Hilton Food Group PLC 465.00 GBp -9.50
Tate & Lyle PLC 588.00 GBp +4.00
View Industry Companies

Industry Analysis


Industry Average

Valuation GLB Industry Range
Price/Earnings 30.4x
Price/Sales 1.8x
Price/Book 5.0x
Price/Cash Flow 22.1x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLANBIA PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at